Agilon Health (NYSE:AGL) Trading 10.3% Higher – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s stock price shot up 10.3% during trading on Monday . The stock traded as high as $89.62 and last traded at $90.18. 226,104 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 368,133 shares. The stock had previously closed at $81.73.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Citigroup reaffirmed a “neutral” rating and set a $80.00 target price (up from $18.75) on shares of Agilon Health in a research report on Friday. Benchmark raised their price target on shares of Agilon Health to $13.00 and gave the stock a “buy” rating in a research note on Thursday, April 2nd. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and raised their price target for the stock from $27.50 to $48.00 in a research note on Thursday, May 7th. JPMorgan Chase & Co. lowered shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target for the company. in a research note on Monday, May 4th. Finally, Wall Street Zen upgraded shares of Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Five equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $45.05.

Agilon Health Price Performance

The firm has a market capitalization of $1.41 billion, a PE ratio of -3.93 and a beta of 2.29. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The business’s 50 day moving average is $25.34 and its two-hundred day moving average is $20.16.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. Equities research analysts anticipate that Agilon Health, Inc. will post -4.17 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Wealthcare Advisory Partners LLC purchased a new position in Agilon Health during the 3rd quarter valued at about $26,000. LPL Financial LLC grew its position in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after purchasing an additional 30,000 shares in the last quarter. Krilogy Financial LLC purchased a new position in shares of Agilon Health during the 4th quarter valued at $34,000. CIBC Bancorp USA Inc. purchased a new position in shares of Agilon Health during the third quarter worth about $34,000. Finally, Merit Financial Group LLC purchased a new position in shares of Agilon Health during the fourth quarter worth about $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.